Bringing the fundamentals into focus…
Back to UroGen Pharma Ltd.
How UroGen Pharma Ltd. stacks up
URGN · against 430 other Healthcare companies of similar size
Overall
31/ 100
Near the bottom of its peers.
Ranked #366 of 431 · scores higher than 14% of peers
Bars: peers in each 10-point band of the overall score69 peers with an overall score of 30–39, including URGN · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around URGN| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 1 | 15.6B DKK (≈$2.3B) | 96 | 96 | 99 | 96 | 0 / 2 | |
| 3 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 4 | 2.29T KRW (≈$1.6B) | 88 | 83 | 90 | 96 | 0 / 2 | |
| 5 | 12.3B CNY (≈$1.7B) | 85 | 83 | 86 | 99 | 0 / 2 | |
| 356 | 1.0B USD | 32 | 0 | — | 1 | 0 / 2 | |
| 356 | 1.9B USD | 32 | 8 | 94 | 17 | 2 / 2 | |
| 366 | 1.8B USD | 31 | 8 | 77 | 29 | 2 / 2 | |
| 366 | 1.1B USD | 31 | 42 | — | 40 | 2 / 2 | |
| 366 | 1.7B USD | 31 | 8 | 94 | 18 | 2 / 2 | |
| 366 | 2.5B USD | 31 | 8 | 64 | 16 | 1 / 2 | |
| 370 | 6.7B CNY (≈$938M) | 30 | 43 | 10 | 50 | 2 / 2 | |
| 370 | 1.7B USD | 30 | 8 | 66 | 15 | 2 / 2 | |
| 370 | 1.3B USD | 30 | 8 | — | 16 | 1 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score